The AGILE Consortium was founded in 2021 by an interdisciplinary group of researchers and clinicians from the Stanford University School of Medicine Departments of  Orthopaedic Surgery, Internal Medicine (including Primary Care and Population Health, Geriatrics, and the Clinical Excellence Research Center), Psychiatry and Behavioral Health, as well as the Graduate School of Business, and Computer Science. The purpose of the Consortium is promote the collaboration of clinicians and researchers from diverse fields to improve the diagnosis and treatment of frailty.

The four main focuses of the AGILE consortium are: 

1. Develop a Community: We host a monthly multidisciplinary seminar series on frailty to serve as a catalyst for collaborations between members of all fields that intersect with the diagnosis, treatment, or prevention of frailty in older adults

2. Identify Opportunities: We focus on known gaps in the clinical care of frail adults, gaps in evidence to guide care clinical care, and operational limitations of identifying and treating frailty while enabling patients to age in place

3. Develop Consensus: Siloed approaches to the research and clinical care of aging adults has created barriers between research, and operationalizing evidence into practice. Our group focuses on the intersection of all of these domains to develop clinically-relevant consensus on the management of frailty.

4. Test: We provide the infrastructure and support to engage all stakeholders, including patients, and guide clinically-meaningful research on frailty

This research is funded by the Gordon and Betty Moore Foundation.

The Gordon and Betty Moore Foundation fosters path-breaking scientific discovery, environmental conservation, patient care improvements and preservation of the special character of the Bay Area. Visit Moore.org and follow @MooreFound on Twitter and Instagram.